MusthInsider

Latest On Crinetics Pharmaceuticals, Inc (CRNX):

Updated on: March 18, 2021

Date/Time	Type	Description	Signal
2023-05-25 19:43 EST	News	Crinetics Pharmaceuticals And Its Value Proposition In Acromegaly	N/A
2023-05-04 23:54 EST	News	Crinetics Pharmaceuticals GAAP EPS of -$0.85 misses by $0.01, revenue of $2.67M beats by $2.43M	N/A
2023-03-06 12:48 EST	News	Evaluating Crinetics' Oral Long Shot For Acromegaly	N/A
2023-02-28 18:44 EST	News	Crinetics Pharmaceuticals GAAP EPS of -$0.84 misses by $0.01, revenue of $0.71M beats by $0.41M	N/A
2022-12-30 22:15 EST	News	Crinetics: FY23 Could Be Turning Point With Two Phase 3 Acromegaly Readouts	N/A
2022-11-29 04:07 EST	News	Crinetics says FDA didn’t clear Phase 2 study request for hyperinsulinism drug	N/A
2022-11-15 00:39 EST	News	Crinetics Pharmaceuticals GAAP EPS of -$0.78 beats by $0.03, revenue of $0.46M beats by $0.26M	N/A
2022-08-12 17:31 EST	News	Crinetics Pharmaceuticals GAAP EPS of -$0.81 misses by $0.15, revenue of $0.44M misses by $0.28M	N/A
2022-06-13 22:31 EST	News	Crinetics: Late-Stage Acromegaly Disease Studies Will Be Major Inflection Point	N/A
2022-05-25 15:30 EST	News	Crinetics hormone CRN04894 therapy shows promise in early-stage study	N/A
2022-05-13 09:56 EST	News	Crinetics Pharmaceuticals GAAP EPS of -$0.73 misses by $0.17, revenue of $3.13M misses by $2.07M	N/A
2022-04-29 23:10 EST	News	Crinetics: An Orphan Disease Innovator On The Rise	N/A
2022-04-24 11:40 EST	News	Crinetics Pharmaceuticals: Endocrinology Focus To Pay Off As Multi-Faceted Pipeline Makes Progress	N/A
2022-04-13 16:17 EST	News	Crinetics Pharmaceuticals prices $125M stock offering	N/A
2022-04-01 04:52 EST	News	Crinetics stock gains on hyperinsulinism candidate's trial data; JMP raises PT	N/A
2022-03-31 09:08 EST	News	Crinetics Pharmaceuticals reports results	N/A
2022-03-30 16:39 EST	News	Crinetics shows dose-dependent effect of hyperinsulinism candidate in early trial	N/A
2022-03-18 16:25 EST	News	Crinetics delays early Phase 1 data for experimental therapy due to COVID-19	N/A
2022-02-28 09:07 EST	News	Crinetics, Sanwa ink licensing deal for cancer/hormonal disorder drug in Japan	N/A
2021-10-22 05:14 EST	News	Crinetics Pharmaceuticals prices $150M in stock offering	N/A
2021-10-21 03:29 EST	News	Crinetics drops after announcing common stock offering	N/A
2021-09-21 15:29 EST	News	Crinetics posts preliminary results from early-stage CRN04777 hyperinsulinism study	N/A
2021-09-21 15:23 EST	News	Crinetics Pharmaceuticals (CRNX) Investor Presentation - Slideshow	N/A
2021-09-02 17:30 EST	News	Crinetics Pharmaceuticals names Jeff Knight as chief operating officer	N/A
2021-08-10 23:06 EST	News	Crinetics Pharmaceuticals posts positive data from early-stage CRN04894 trial	N/A
2021-08-10 23:05 EST	News	Crinetics Pharmaceuticals EPS misses by $0.10	N/A
2021-07-29 16:43 EST	News	Crinetics Pharmaceuticals proposes $15M in private placement with Frazier Healthcare	N/A
2021-07-21 02:52 EST	News	Crinetics doses first patient in late-stage oral paltusotine acromegaly trial	N/A
2021-05-07 06:27 EST	News	Crinetics Pharmaceuticals EPS misses by $0.04	N/A
2021-04-08 07:33 EST	News	Crinetics Pharma raises $75M via equity offering	N/A
2021-03-30 23:41 EST	News	Crinetics Pharmaceuticals, Inc. (CRNX) CEO Scott Struthers on Q4 2020 Results - Earnings Call Transcript	N/A
2021-03-30 23:41 EST	News	Crinetics Pharmaceuticals, Inc. 2020 Q4 - Results - Earnings Call Presentation	N/A
2021-01-23 04:21 EST	News	Crinetics Pharmaceuticals (CRNX) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow	N/A
2020-12-13 03:42 EST	Financials	Company financials have been released.	Neutral
2020-11-24 07:37 EST	Analyst Rating	The Analyst Target Price has increased from $32.8 to $33.6.	Buy
2020-11-09 11:40 EST	Financials	Company financials have been released.	Neutral
2020-11-09 11:40 EST	Earnings Estimate	An EPS average of -$0.59 is estimated for the quarter ending on March 31, 2021.	Sell
2020-11-07 15:30 EST	Financials	Company financials have been released.	Neutral
2020-11-07 06:16 EST	News	Crinetics Pharmaceuticals EPS misses by $0.03	N/A
2020-10-30 12:37 EST	Analyst Rating	The Analyst Target Price has decreased from $36.75 to $32.8.	Neutral
2020-10-26 14:41 EST	News	Crinetics Pharma lead drug successful in mid-stage acromegaly study	N/A
2020-09-26 12:27 EST	Financials	Company financials have been released.	Neutral
2020-09-17 04:35 EST	Financials	Company financials have been released.	Neutral
2020-09-08 04:25 EST	Analyst Rating	The Analyst Target Price has decreased from $36.8 to $36.75.	Neutral
2020-09-05 01:11 EST	News	Crinetics Pharma to advance ACTH antagonist candidate into the clinic	N/A
2020-09-05 00:31 EST	Financials	Company financials have been released.	Neutral
2020-09-02 11:29 EST	News	Crinetics Pharmaceuticals- Superior Molecules In Endocrinology	N/A
2020-08-09 08:28 EST	Financials	Company financials have been released.	Neutral
2020-08-07 16:03 EST	News	Crinetics Pharmaceuticals EPS beats by $0.02	N/A
2020-07-31 00:39 EST	Financials	Company financials have been released.	Neutral

About Crinetics Pharmaceuticals, Inc (CRNX):

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is paltusotine, an oral selective nonpeptide somatostatin receptor type 2 biased agonist, which is in Phase I clinical trials used for the treatment of acromegaly and neuroendocrine tumors. The company is also developing CRN01941, an oral selective nonpeptide sst2 biased agonist designed for the treatment of neuroendocrine tumors; an oral selective nonpeptide somatostatin type 5 receptor agonist for treating congenital hyperinsulinism; and an oral adrenocorticotrophic hormone antagonist for the treatment of cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was founded in 2008 and is headquartered in San Diego, California.

See Advanced Chart

General

Name Crinetics Pharmaceuticals, Inc
Symbol CRNX
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 68
Fiscal Year EndDecember
IPO Date2018-07-18
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryBiotechnology
Web URLhttp://www.crinetics.com

Valuation

Price/Sales (Trailing 12 Mt.) 1102.47
Price/Book (Most Recent Quarter) 2.99
Enterprise Value Revenue 961.96

Financials

Most Recent Quarter 2020-09-30
Next Quarter EPS Estimate -$0.55
Operating Margin -17443%
Return on Assets -25%
Return on Equity -42%
Revenue 392000
Earnings Per Share -$1.62
Revenue Per Share $0.01
Gross Profit -40313000
Quarterly Earnings Growth -80.7%

Highlights

Market Capitalization 531.37 million
EBITDA -40113000
PE Ratio -16.43
Analyst Target Price $33.6
Book Value Per Share $5.69

Share Statistics

Shares Outstanding 32.92 million
Shares Float 20.69 million
% Held by Insiders 450%
% Held by Institutions 95.14%
Shares Short 1.53 million
Shares Short Prior Month 1.38 million
Short Ratio 13.29
Short % of Float 6%
Short % of Shares Outstanding 5%

Technicals

Beta 1.23
52 Week High $23.7
52 Week Low $11.61
50 Day Moving Average 15.77
200 Day Moving Average 14.69

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Crinetics Pharmaceuticals, Inc (CRNX) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Crinetics Pharmaceuticals, Inc (CRNX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-09-30	2020-11-06	$N/A	-$0.56	-$0.53	-6.38%
2020-06-30	2020-08-07	$N/A	-$0.53	-$0.55	4.21%
2020-03-31	2020-05-08	$N/A	-$0.71	-$0.63	-12.66%
2019-12-31	2020-03-09	$321000	-$0.60	-$0.68	11.35%
2019-09-30	2019-11-12	$505000	-$0.60	-$0.54	-11.92%
2019-06-30	2019-08-13	$N/A	-$0.51	-$0.46	-11.79%
2019-03-31	2019-05-13	$367000	-$0.37	-$0.39	4.61%
2018-12-31	2019-03-13	$781000	-$0.35	-$0.41	15.09%
2018-09-30	2018-11-13	$548000	-$0.38	-$0.34	-10.47%
2018-06-30	2018-08-30	$657000	-$0.33	-$0.31	-7.32%

Crinetics Pharmaceuticals, Inc (CRNX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares

Cash Flow:

Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures

Balance Sheet:

Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Crinetics Pharmaceuticals, Inc (CRNX) Chart:

Crinetics Pharmaceuticals, Inc (CRNX) News:

Below you will find a list of latest news for Crinetics Pharmaceuticals, Inc (CRNX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Crinetics Pharmaceuticals, Inc (CRNX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent
2026-06-18	20	0	CALL	0	0	121.26	TRUE	0	0
2026-06-18	25	0	CALL	0	10	82.84	TRUE	0	0
2026-06-18	30	8.4	CALL	0	45	51.14	TRUE	0	0
2026-06-18	34	0	CALL	0	2	55.79	TRUE	0	0
2026-06-18	35	4.11	CALL	0	5	55.86	TRUE	0	0
2026-06-18	36	0	CALL	0	0	54.53	TRUE	0	0
2026-06-18	37	0	CALL	0	0	52.56	TRUE	0	0
2026-06-18	38	5.8	CALL	0	0	55.27	TRUE	0	0
2026-06-18	39	2.2	CALL	7	30	51.8	FALSE	2.2	0
2026-06-18	40	1.8	CALL	4	158	51.81	FALSE	0.5	0.38
2026-06-18	41	0	CALL	0	0	53.85	FALSE	0	0
2026-06-18	42	2.7	CALL	0	8	62.85	FALSE	0	0
2026-06-18	43	0	CALL	0	27	66.82	FALSE	0	0
2026-06-18	44	0	CALL	0	2	71.45	FALSE	0	0
2026-06-18	45	2	CALL	0	209	75.69	FALSE	0	0
2026-06-18	46	2.5	CALL	0	1	79.57	FALSE	0	0
2026-06-18	47	0	CALL	0	0	83.79	FALSE	0	0
2026-06-18	48	0	CALL	0	9	87.76	FALSE	0	0
2026-06-18	49	0	CALL	0	0	92.19	FALSE	0	0
2026-06-18	50	1	CALL	0	57	95.75	FALSE	0	0
2026-06-18	55	0	CALL	0	14	113.3	FALSE	0	0
2026-06-18	60	0	CALL	0	28	127.91	FALSE	0	0
2026-06-18	65	0.25	CALL	0	28	97.67	FALSE	0	0
2026-06-18	70	0.1	CALL	0	20	152.88	FALSE	0	0
2026-06-18	75	0	CALL	0	40	163.26	FALSE	0	0
2026-06-18	80	0	CALL	0	26	172.57	FALSE	0	0
2026-06-18	85	0	CALL	0	0	181.99	FALSE	0	0
2026-06-18	20	0	PUT	0	0	190.68	FALSE	0	0
2026-06-18	25	0	PUT	0	8	138.17	FALSE	0	0
2026-06-18	30	0.75	PUT	0	54	67.13	FALSE	0	0
2026-06-18	34	1.6	PUT	0	43	62.19	FALSE	0	0
2026-06-18	35	2	PUT	0	2	65.41	FALSE	0	0
2026-06-18	36	1.95	PUT	0	24	70.94	FALSE	0	0
2026-06-18	37	2.4	PUT	0	9	62.14	FALSE	0	0
2026-06-18	38	2.66	PUT	6	19	61.03	FALSE	2.66	0
2026-06-18	39	0	PUT	0	3	56.26	TRUE	0	0
2026-06-18	40	3.6	PUT	0	6	53.13	TRUE	0	0
2026-06-18	41	0	PUT	0	0	56.88	TRUE	0	0
2026-06-18	42	0	PUT	0	5	51.59	TRUE	0	0
2026-06-18	43	0	PUT	0	2	51.92	TRUE	0	0
2026-06-18	44	0	PUT	0	10	51.79	TRUE	0	0
2026-06-18	45	9.35	PUT	0	64	71.72	TRUE	0	0
2026-06-18	46	0	PUT	0	0	58.18	TRUE	0	0
2026-06-18	47	0	PUT	0	0	57.15	TRUE	0	0
2026-06-18	48	0	PUT	0	26	61.13	TRUE	0	0
2026-06-18	49	0	PUT	0	0	62.87	TRUE	0	0
2026-06-18	50	0	PUT	0	15	64.22	TRUE	0	0
2026-06-18	55	0	PUT	0	4	74.47	TRUE	0	0
2026-06-18	60	0	PUT	0	0	84.05	TRUE	0	0
2026-06-18	65	0	PUT	0	0	95.86	TRUE	0	0
2026-06-18	70	0	PUT	0	0	0	TRUE	0	0
2026-06-18	75	0	PUT	0	0	0	TRUE	0	0
2026-06-18	80	0	PUT	0	0	109.02	TRUE	0	0
2026-06-18	85	0	PUT	0	0	116.86	TRUE	0	0
2026-07-17	29	0	CALL	0	0	40.2	TRUE	0	0
2026-07-17	30	0	CALL	0	0	44.01	TRUE	0	0
2026-07-17	31	0	CALL	0	0	46.56	TRUE	0	0
2026-07-17	32	0	CALL	0	0	49.75	TRUE	0	0
2026-07-17	33	0	CALL	0	0	51.05	TRUE	0	0
2026-07-17	34	0	CALL	0	0	51.14	TRUE	0	0
2026-07-17	35	0	CALL	0	0	50.32	TRUE	0	0
2026-07-17	36	0	CALL	0	0	50.05	TRUE	0	0
2026-07-17	37	0	CALL	0	0	48.96	TRUE	0	0
2026-07-17	38	0	CALL	0	0	50.71	TRUE	0	0
2026-07-17	39	0	CALL	0	0	47.31	FALSE	0	0
2026-07-17	40	0	CALL	0	0	49.03	FALSE	0	0
2026-07-17	41	0	CALL	0	0	51.24	FALSE	0	0
2026-07-17	42	0	CALL	0	0	54.07	FALSE	0	0
2026-07-17	43	0	CALL	0	0	55.19	FALSE	0	0
2026-07-17	44	0	CALL	0	0	57.09	FALSE	0	0
2026-07-17	45	0	CALL	0	0	59.04	FALSE	0	0
2026-07-17	29	0	PUT	0	0	82.79	FALSE	0	0
2026-07-17	30	0	PUT	0	0	78.69	FALSE	0	0
2026-07-17	31	0	PUT	0	0	74.99	FALSE	0	0
2026-07-17	32	0	PUT	0	0	70.56	FALSE	0	0
2026-07-17	33	0	PUT	0	0	67.95	FALSE	0	0
2026-07-17	34	0	PUT	0	0	64.95	FALSE	0	0
2026-07-17	35	0	PUT	0	0	62.89	FALSE	0	0
2026-07-17	36	0	PUT	0	0	62.01	FALSE	0	0
2026-07-17	37	0	PUT	0	0	59.7	FALSE	0	0
2026-07-17	38	0	PUT	0	0	57.63	FALSE	0	0
2026-07-17	39	0	PUT	0	0	57.31	TRUE	0	0
2026-07-17	40	0	PUT	0	0	55.95	TRUE	0	0
2026-07-17	41	0	PUT	0	0	55.89	TRUE	0	0
2026-07-17	42	0	PUT	0	0	58.03	TRUE	0	0
2026-07-17	43	0	PUT	0	0	57.2	TRUE	0	0
2026-07-17	44	0	PUT	0	0	57.47	TRUE	0	0
2026-07-17	45	0	PUT	0	0	61.68	TRUE	0	0
2026-09-18	20	0	CALL	0	2	80.96	TRUE	0	0
2026-09-18	25	0	CALL	0	0	52.1	TRUE	0	0
2026-09-18	30	10	CALL	1	13	54.79	TRUE	10	0
2026-09-18	35	0	CALL	0	0	56.17	TRUE	0	0
2026-09-18	40	4.39	CALL	1	66	54.4	FALSE	4.39	0
2026-09-18	45	3.08	CALL	0	9	55.14	FALSE	0	0
2026-09-18	50	0	CALL	0	25	57.79	FALSE	0	0
2026-09-18	55	0	CALL	0	36	49.97	FALSE	0	0
2026-09-18	60	0	CALL	0	4	68.34	FALSE	0	0
2026-09-18	65	0	CALL	0	4	74.17	FALSE	0	0
2026-09-18	70	0	CALL	0	1	80.37	FALSE	0	0
2026-09-18	75	0	CALL	0	0	85.88	FALSE	0	0
2026-09-18	80	0	CALL	0	1	90.83	FALSE	0	0
2026-09-18	85	0	CALL	0	0	95.82	FALSE	0	0
2026-09-18	20	0	PUT	0	11	104.81	FALSE	0	0
2026-09-18	25	0.9	PUT	0	151	80.91	FALSE	0	0
2026-09-18	30	0	PUT	0	7	73.92	FALSE	0	0
2026-09-18	35	2.75	PUT	0	40	66.12	FALSE	0	0
2026-09-18	40	5.05	PUT	0	51	58.06	TRUE	0	0
2026-09-18	45	0	PUT	0	2	55.9	TRUE	0	0
2026-09-18	50	0	PUT	0	0	51.46	TRUE	0	0
2026-09-18	55	0	PUT	0	0	50.19	TRUE	0	0
2026-09-18	60	0	PUT	0	3	51.26	TRUE	0	0
2026-09-18	65	0	PUT	0	1	52.25	TRUE	0	0
2026-09-18	70	0	PUT	0	0	58.31	TRUE	0	0
2026-09-18	75	0	PUT	0	0	63.9	TRUE	0	0
2026-09-18	80	0	PUT	0	0	69.11	TRUE	0	0
2026-09-18	85	0	PUT	0	0	73.98	TRUE	0	0
2026-12-18	20	18.43	CALL	0	3	74.04	TRUE	0	0
2026-12-18	25	0	CALL	0	0	69.14	TRUE	0	0
2026-12-18	30	0	CALL	0	0	63.96	TRUE	0	0
2026-12-18	32	0	CALL	0	0	64.51	TRUE	0	0
2026-12-18	33	0	CALL	0	0	63.89	TRUE	0	0
2026-12-18	34	0	CALL	0	0	63.56	TRUE	0	0
2026-12-18	35	0	CALL	0	0	63.5	TRUE	0	0
2026-12-18	36	8.86	CALL	0	2	63.24	TRUE	0	0
2026-12-18	37	0	CALL	0	0	63.24	TRUE	0	0
2026-12-18	38	0	CALL	0	0	63.05	TRUE	0	0
2026-12-18	39	0	CALL	0	0	62.69	FALSE	0	0
2026-12-18	40	6.98	CALL	0	12	62.16	FALSE	0	0
2026-12-18	41	0	CALL	0	2	61.9	FALSE	0	0
2026-12-18	42	0	CALL	0	0	63.19	FALSE	0	0
2026-12-18	43	0	CALL	0	0	62.63	FALSE	0	0
2026-12-18	44	0	CALL	0	0	61.92	FALSE	0	0
2026-12-18	45	0	CALL	0	3	62.76	FALSE	0	0
2026-12-18	46	0	CALL	0	0	61.99	FALSE	0	0
2026-12-18	47	0	CALL	0	0	60.87	FALSE	0	0
2026-12-18	48	0	CALL	0	0	61.77	FALSE	0	0
2026-12-18	50	2.9	CALL	0	27	59.5	FALSE	0	0
2026-12-18	55	2.6	CALL	0	3	59.72	FALSE	0	0
2026-12-18	60	2.16	CALL	0	2	59.25	FALSE	0	0
2026-12-18	20	0	PUT	0	0	84.59	FALSE	0	0
2026-12-18	25	1.9	PUT	0	1	69.81	FALSE	0	0
2026-12-18	30	0	PUT	0	0	62.39	FALSE	0	0
2026-12-18	32	0	PUT	0	0	62.67	FALSE	0	0
2026-12-18	33	0	PUT	0	0	62.54	FALSE	0	0
2026-12-18	34	0	PUT	0	0	62.17	FALSE	0	0
2026-12-18	35	5.2	PUT	0	35	61.83	FALSE	0	0
2026-12-18	36	0	PUT	0	0	62.21	FALSE	0	0
2026-12-18	37	0	PUT	0	0	61.92	FALSE	0	0
2026-12-18	38	0	PUT	0	0	61.43	FALSE	0	0
2026-12-18	39	0	PUT	0	0	61.65	TRUE	0	0
2026-12-18	40	0	PUT	0	0	61.68	TRUE	0	0
2026-12-18	41	0	PUT	0	0	60.68	TRUE	0	0
2026-12-18	42	0	PUT	0	0	60.8	TRUE	0	0
2026-12-18	43	0	PUT	0	0	60.75	TRUE	0	0
2026-12-18	44	0	PUT	0	0	60.13	TRUE	0	0
2026-12-18	45	11.55	PUT	0	30	61.06	TRUE	0	0
2026-12-18	46	0	PUT	0	0	59.28	TRUE	0	0
2026-12-18	47	0	PUT	0	0	59.49	TRUE	0	0
2026-12-18	48	0	PUT	0	10	59.14	TRUE	0	0
2026-12-18	50	0	PUT	0	0	58.44	TRUE	0	0
2026-12-18	55	0	PUT	0	0	56.36	TRUE	0	0
2026-12-18	60	0	PUT	0	0	52.99	TRUE	0	0

Latest CRNX Trades:

Date	Shares	Price
Jun 13, 2022 7:59 PM EST	5	$17.17
Jun 13, 2022 7:59 PM EST	100	$17.19
Jun 13, 2022 7:59 PM EST	1	$17.17
Jun 13, 2022 7:59 PM EST	100	$17.2
Jun 13, 2022 7:59 PM EST	100	$17.2

Crinetics Pharmaceuticals, Inc (CRNX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-06-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120038179/0001209191-20-038179-index.htm
2018-07-10	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1658247/000000000018021079/0000000000-18-021079-index.htm
2019-08-16	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1658247/000000000019012560/0000000000-19-012560-index.htm
2018-09-10	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000031506618002299/0000315066-18-002299-index.htm
2019-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000031506619000968/0000315066-19-000968-index.htm
2020-02-07	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000031506620000861/0000315066-20-000861-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318019963/0000899243-18-019963-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318019964/0000899243-18-019964-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318019965/0000899243-18-019965-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318019967/0000899243-18-019967-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318019968/0000899243-18-019968-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318019972/0000899243-18-019972-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318019974/0000899243-18-019974-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318019975/0000899243-18-019975-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318019978/0000899243-18-019978-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318019979/0000899243-18-019979-index.htm
2018-07-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924318020264/0000899243-18-020264-index.htm
2019-02-12	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924319003318/0000899243-19-003318-index.htm
2019-02-12	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924319003326/0000899243-19-003326-index.htm
2020-04-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000089924320010940/0000899243-20-010940-index.htm
2018-07-30	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000094787118000610/0000947871-18-000610-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000101297518000919/0001012975-18-000919-index.htm
2018-07-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000101297518000925/0001012975-18-000925-index.htm
2018-08-27	4/A	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000101297518001046/0001012975-18-001046-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000110465918045567/0001104659-18-045567-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000110465918045579/0001104659-18-045579-index.htm
2018-07-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000110465918046292/0001104659-18-046292-index.htm
2018-07-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm
2018-07-30	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000110465918048071/0001104659-18-048071-index.htm
2019-01-24	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm
2019-02-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000110465919006113/0001104659-19-006113-index.htm
2019-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000110465919008632/0001104659-19-008632-index.htm
2019-02-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000110465919010154/0001104659-19-010154-index.htm
2019-03-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm
2019-06-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm
2020-02-06	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000110465920011470/0001104659-20-011470-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000110465920021136/0001104659-20-021136-index.htm
2019-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000114420419008307/0001144204-19-008307-index.htm
2020-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000117266120000650/0001172661-20-000650-index.htm
2018-07-12	8-A12B	Registration of securities [Section 12(b)]	https://www.sec.gov/Archives/edgar/data/1658247/000119312518216421/0001193125-18-216421-index.htm
2018-07-13	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1658247/000119312518217820/0001193125-18-217820-index.htm
2018-07-13	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1658247/000119312518217824/0001193125-18-217824-index.htm
2018-07-17	S-1MEF	Registration adding securities to prior Form S-1 registration [Rule 462(b)]	https://www.sec.gov/Archives/edgar/data/1658247/000119312518219860/0001193125-18-219860-index.htm
2018-07-18	424B4	Prospectus [Rule 424(b)(4)]	https://www.sec.gov/Archives/edgar/data/1658247/000119312518220701/0001193125-18-220701-index.htm
2018-07-18	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1658247/000119312518220704/0001193125-18-220704-index.htm
2018-07-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000119312518222517/0001193125-18-222517-index.htm
2018-07-30	SC 13D	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1658247/000119312518231543/0001193125-18-231543-index.htm
2018-08-28	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1658247/000119312518259557/0001193125-18-259557-index.htm
2018-08-30	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000119312518263610/0001193125-18-263610-index.htm
2018-10-01	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000119312518289506/0001193125-18-289506-index.htm
2018-11-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000119312518325476/0001193125-18-325476-index.htm
2019-08-13	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1658247/000119312519220012/0001193125-19-220012-index.htm
2019-08-19	S-3/A	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1658247/000119312519224488/0001193125-19-224488-index.htm
2019-08-19	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1658247/000119312519224495/0001193125-19-224495-index.htm
2019-08-27	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1658247/000119312519230761/0001193125-19-230761-index.htm
2020-04-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000119312520099551/0001193125-20-099551-index.htm
2020-04-14	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1658247/000119312520107151/0001193125-20-107151-index.htm
2020-04-14	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000119312520107156/0001193125-20-107156-index.htm
2020-04-15	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000119312520108092/0001193125-20-108092-index.htm
2020-04-15	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1658247/000119312520108096/0001193125-20-108096-index.htm
2020-04-20	SC 13D/A	General statement of acquisition of beneficial ownership	https://www.sec.gov/Archives/edgar/data/1658247/000119312520111625/0001193125-20-111625-index.htm
2019-03-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119018982/0001209191-19-018982-index.htm
2019-03-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119018983/0001209191-19-018983-index.htm
2019-03-12	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119018984/0001209191-19-018984-index.htm
2019-06-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119038894/0001209191-19-038894-index.htm
2019-06-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119038896/0001209191-19-038896-index.htm
2019-06-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119038897/0001209191-19-038897-index.htm
2019-06-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119038902/0001209191-19-038902-index.htm
2019-06-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119038905/0001209191-19-038905-index.htm
2019-07-16	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119042285/0001209191-19-042285-index.htm
2019-07-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119042286/0001209191-19-042286-index.htm
2019-08-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119045039/0001209191-19-045039-index.htm
2019-12-18	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm
2020-02-11	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120008269/0001209191-20-008269-index.htm
2020-02-11	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120008272/0001209191-20-008272-index.htm
2020-02-11	5	Annual statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120008280/0001209191-20-008280-index.htm
2020-02-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120012974/0001209191-20-012974-index.htm
2020-02-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120012987/0001209191-20-012987-index.htm
2020-02-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120012997/0001209191-20-012997-index.htm
2020-03-27	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120021372/0001209191-20-021372-index.htm
2020-04-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120026196/0001209191-20-026196-index.htm
2020-06-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120038153/0001209191-20-038153-index.htm
2020-06-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120038161/0001209191-20-038161-index.htm
2020-06-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120038166/0001209191-20-038166-index.htm
2020-06-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120038172/0001209191-20-038172-index.htm
2020-06-22	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120038179/0001209191-20-038179-index.htm
2020-07-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm
2020-09-03	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120049508/0001209191-20-049508-index.htm
2020-09-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000120919120049518/0001209191-20-049518-index.htm
2020-01-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-02-06	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-02-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000121390020003601/0001213900-20-003601-index.htm
2020-03-11	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-04-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2020-06-11	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000121390020014709/0001213900-20-014709-index.htm
2018-07-12	CERT	Certification	https://www.sec.gov/Archives/edgar/data/1658247/000135445718000250/0001354457-18-000250-index.htm
2018-08-30	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1658247/000156459018022504/0001564590-18-022504-index.htm
2018-11-13	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1658247/000156459018029304/0001564590-18-029304-index.htm
2019-03-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459019007555/0001564590-19-007555-index.htm
2019-03-13	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1658247/000156459019007561/0001564590-19-007561-index.htm
2019-04-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459019011511/0001564590-19-011511-index.htm
2019-04-29	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1658247/000156459019013719/0001564590-19-013719-index.htm
2019-04-29	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1658247/000156459019013723/0001564590-19-013723-index.htm
2019-05-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459019018827/0001564590-19-018827-index.htm
2019-05-13	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1658247/000156459019018831/0001564590-19-018831-index.htm
2019-06-25	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459019023431/0001564590-19-023431-index.htm
2019-07-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459019025016/0001564590-19-025016-index.htm
2019-08-13	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459019031797/0001564590-19-031797-index.htm
2019-08-13	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1658247/000156459019031801/0001564590-19-031801-index.htm
2019-11-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459019042893/0001564590-19-042893-index.htm
2019-11-12	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1658247/000156459019042900/0001564590-19-042900-index.htm
2020-02-11	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000156459020004205/0001564590-20-004205-index.htm
2020-03-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459020009362/0001564590-20-009362-index.htm
2020-03-09	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1658247/000156459020009365/0001564590-20-009365-index.htm
2020-04-28	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1658247/000156459020019202/0001564590-20-019202-index.htm
2020-04-28	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1658247/000156459020019210/0001564590-20-019210-index.htm
2020-05-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459020023260/0001564590-20-023260-index.htm
2020-05-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1658247/000156459020023265/0001564590-20-023265-index.htm
2020-06-22	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459020030117/0001564590-20-030117-index.htm
2020-08-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459020038067/0001564590-20-038067-index.htm
2020-08-07	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1658247/000156459020038069/0001564590-20-038069-index.htm
2020-09-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459020042431/0001564590-20-042431-index.htm
2020-09-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459020044046/0001564590-20-044046-index.htm
2020-10-26	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459020047499/0001564590-20-047499-index.htm
2020-11-06	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1658247/000156459020051684/0001564590-20-051684-index.htm
2020-11-06	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1658247/000156459020051686/0001564590-20-051686-index.htm
2018-07-17	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000161577418006600/0001615774-18-006600-index.htm
2018-07-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2018-07-26	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1658247/000161577418006903/0001615774-18-006903-index.htm
2019-03-25	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2018-07-17	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1658247/999999999518001811/9999999995-18-001811-index.htm
2019-08-29	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1658247/999999999519002011/9999999995-19-002011-index.htm

Crinetics Pharmaceuticals, Inc (CRNX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Crinetics Pharmaceuticals, Inc (CRNX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 450%
Institutional Ownership: 9514%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2019-03-18	5AM Ventures IV, L.P.	10% Share Holder	Sell	6,194.00	24.25	150,208.84	104,489.00	https://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm
2019-08-05	Richard Scott Struthers	President & CEO	Buy	10,000.00	1.91	19,100.00	1,225,805.00	https://www.sec.gov/Archives/edgar/data/1658247/000120919119045039/0001209191-19-045039-index.htm
2019-12-16	Matthew K Fust	Director	Sell	3,500.00	22.50	78,750.00	12,536.00	https://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm
2019-01-22	5AM Ventures IV, L.P.	10% Share Holder	Sell	10,486.00	21.88	229,381.25	129,483.00	https://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm
2018-07-20	5AM Ventures IV, L.P.	10% Share Holder	Buy	4,600.00	17.00	78,200.00	139,969.00	https://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm
2018-07-20	Vivo Capital VIII, LLC	10% Share Holder	Buy	141,177.00	17.00	2,400,009.00	141,177.00	https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2019-12-16	Matthew K Fust	Director	Buy	3,500.00	1.91	6,685.00	16,036.00	https://www.sec.gov/Archives/edgar/data/1658247/000120919119061184/0001209191-19-061184-index.htm
2020-03-09	Vivo Capital VIII, LLC	10% Share Holder	Sell	133.00	19.50	2,593.50	168,165.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-02-10	Vivo Capital VIII, LLC	10% Share Holder	Sell	5,904.00	21.40	126,345.60	168,298.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-07	Vivo Capital VIII, LLC	10% Share Holder	Sell	4,614.00	22.00	101,508.00	174,202.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-04	Vivo Capital VIII, LLC	10% Share Holder	Sell	10,519.00	22.80	239,833.20	178,816.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-01-31	Vivo Capital VIII, LLC	10% Share Holder	Sell	4,220.00	21.70	91,574.00	189,335.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-30	Vivo Capital VIII, LLC	10% Share Holder	Sell	5,940.00	22.10	131,274.00	193,555.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-29	Vivo Capital VIII, LLC	10% Share Holder	Sell	10,878.00	22.20	241,491.60	199,495.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2018-07-20	Alan Seth Krasner	Chief Medical Officer	Buy	2,000.00	17.00	34,000.00	2,000.00	https://www.sec.gov/Archives/edgar/data/1658247/000089924318020264/0000899243-18-020264-index.htm
2019-03-20	Vivo Capital VIII, LLC	10% Share Holder	Sell	83,984.00	22.25	1,868,644.00	210,373.00	https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2020-04-17	Vivo Capital VIII, LLC	10% Share Holder	Sell	74,333.00	15.40	1,144,728.20	2,162,587.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2020-04-16	Vivo Capital VIII, LLC	10% Share Holder	Sell	26,527.00	15.20	403,210.40	2,236,920.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2020-04-15	Vivo Capital VIII, LLC	10% Share Holder	Sell	189,625.00	15.50	2,939,187.50	2,263,447.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2019-06-21	5AM Ventures IV, L.P.	Insider	Sell	240,000.00	22.20	5,328,000.00	2,267,797.00	https://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm
2018-07-20	PERCEPTIVE ADVISORS LLC	Director	Buy	400,000.00	17.00	6,800,000.00	2,280,305.00	https://www.sec.gov/Archives/edgar/data/1658247/000101297518000925/0001012975-18-000925-index.htm
2020-04-07	Vivo Capital VIII, LLC	10% Share Holder	Sell	5,373.00	14.20	76,296.60	2,453,072.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-03	Vivo Capital VIII, LLC	10% Share Holder	Sell	263,600.00	13.80	3,637,680.00	2,458,445.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2019-03-18	5AM Ventures IV, L.P.	10% Share Holder	Sell	148,645.00	24.25	3,604,745.30	2,507,797.00	https://www.sec.gov/Archives/edgar/data/1658247/000110465919016338/0001104659-19-016338-index.htm
2020-03-09	Vivo Capital VIII, LLC	10% Share Holder	Sell	347.00	19.50	6,766.50	2,722,045.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-02-10	Vivo Capital VIII, LLC	10% Share Holder	Sell	1,451.00	21.40	31,051.40	2,722,392.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-07	Vivo Capital VIII, LLC	10% Share Holder	Sell	1,134.00	22.00	24,948.00	2,723,843.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-04	Vivo Capital VIII, LLC	10% Share Holder	Sell	2,584.00	22.80	58,915.20	2,724,977.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-01-31	Vivo Capital VIII, LLC	10% Share Holder	Sell	1,037.00	21.70	22,502.90	2,727,561.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-30	Vivo Capital VIII, LLC	10% Share Holder	Sell	1,459.00	22.10	32,243.90	2,728,598.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-29	Vivo Capital VIII, LLC	10% Share Holder	Sell	2,673.00	22.20	59,340.60	2,730,057.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2019-03-20	Vivo Capital VIII, LLC	10% Share Holder	Sell	292,609.00	22.25	6,510,550.25	2,732,730.00	https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2018-07-20	Vivo Capital VIII, LLC	10% Share Holder	Buy	153,180.00	20.73	3,175,421.40	294,357.00	https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2020-04-17	Vivo Capital VIII, LLC	10% Share Holder	Sell	10,265.00	15.40	158,081.00	298,625.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2018-07-20	Vivo Capital VIII, LLC	10% Share Holder	Buy	51,686.00	17.00	878,662.00	3,025,339.00	https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2020-04-16	Vivo Capital VIII, LLC	10% Share Holder	Sell	3,663.00	15.20	55,677.60	308,890.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2019-01-22	5AM Ventures IV, L.P.	10% Share Holder	Sell	251,667.00	21.88	5,505,215.63	3,107,642.00	https://www.sec.gov/Archives/edgar/data/1658247/000110465919003219/0001104659-19-003219-index.htm
2020-04-15	Vivo Capital VIII, LLC	10% Share Holder	Sell	26,185.00	15.50	405,867.50	312,553.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020009500/0001213900-20-009500-index.htm
2018-07-20	5AM Ventures IV, L.P.	10% Share Holder	Buy	110,400.00	17.00	1,876,800.00	3,359,309.00	https://www.sec.gov/Archives/edgar/data/1658247/000110465918046330/0001104659-18-046330-index.htm
2020-04-07	Vivo Capital VIII, LLC	10% Share Holder	Sell	742.00	14.20	10,536.40	338,738.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-03	Vivo Capital VIII, LLC	10% Share Holder	Sell	36,400.00	13.80	502,320.00	339,480.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020008792/0001213900-20-008792-index.htm
2020-04-17	PERCEPTIVE ADVISORS LLC	10% Share Holder	Buy	1,071,428.00	14.00	14,999,992.00	3,659,381.00	https://www.sec.gov/Archives/edgar/data/1658247/000089924320010940/0000899243-20-010940-index.htm
2020-03-09	Vivo Capital VIII, LLC	10% Share Holder	Sell	48.00	19.50	936.00	375,880.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020006030/0001213900-20-006030-index.htm
2020-02-10	Vivo Capital VIII, LLC	10% Share Holder	Sell	200.00	21.40	4,280.00	375,928.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-07	Vivo Capital VIII, LLC	10% Share Holder	Sell	157.00	22.00	3,454.00	376,128.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020003326/0001213900-20-003326-index.htm
2020-02-04	Vivo Capital VIII, LLC	10% Share Holder	Sell	357.00	22.80	8,139.60	376,285.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002831/0001213900-20-002831-index.htm
2020-01-31	Vivo Capital VIII, LLC	10% Share Holder	Sell	143.00	21.70	3,103.10	376,642.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-30	Vivo Capital VIII, LLC	10% Share Holder	Sell	201.00	22.10	4,442.10	376,785.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2020-01-29	Vivo Capital VIII, LLC	10% Share Holder	Sell	369.00	22.20	8,191.80	376,986.00	https://www.sec.gov/Archives/edgar/data/1658247/000121390020002314/0001213900-20-002314-index.htm
2019-03-20	Vivo Capital VIII, LLC	10% Share Holder	Sell	40,407.00	22.25	899,055.75	377,355.00	https://www.sec.gov/Archives/edgar/data/1658247/000161577419004434/0001615774-19-004434-index.htm
2018-07-20	Vivo Capital VIII, LLC	10% Share Holder	Buy	7,137.00	17.00	121,329.00	417,762.00	https://www.sec.gov/Archives/edgar/data/1658247/000161577418006729/0001615774-18-006729-index.htm
2020-07-16	Richard Scott Struthers	President & CEO	Sell	17,500.00	14.46	253,107.75	890,805.00	https://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm
2020-07-15	Richard Scott Struthers	President & CEO	Sell	17,500.00	15.30	267,722.00	908,305.00	https://www.sec.gov/Archives/edgar/data/1658247/000120919120042897/0001209191-20-042897-index.htm
2019-06-21	5AM Ventures IV, L.P.	Insider	Sell	10,000.00	22.20	222,000.00	94,489.00	https://www.sec.gov/Archives/edgar/data/1658247/000110465919037468/0001104659-19-037468-index.htm
2020-04-28	WENDALL WIERENGA	Director	Buy	25,329.00	0.73	18,490.17	99,846.00	https://www.sec.gov/Archives/edgar/data/1658247/000120919120026196/0001209191-20-026196-index.htm

Crinetics Pharmaceuticals, Inc

(NASDAQ:CRNX)